Table 5.
Cardiovascular deaths prevented or postponed according to scenarios of sodium intake reduction by type of cause1, Mexico 2019
| Intermediate2 | Optimistic3 | |||
|---|---|---|---|---|
| DPP (95% UI) | % DPP | DPP (95% UI) | % DPP | |
| Total (CVD) | 5,200 (2,007–8,769) | 100 | 13,900 (5,915 − 21,807) | 100 |
| Ischemic heart disease | 2,400 (936-3,944) | 46.2 | 6,600 (2,811 − 10,388) | 47.5 |
| Hypertensive disease | 1,600 (616-2,927) | 30.8 | 4,200 (1,756-6,399) | 30.2 |
| Stroke | 1,000 (371-1,583) | 19.2 | 2,600 (1,092 − 4,064) | 18.7 |
| Others * | 200 (73–342) | 3.8 | 500 (200–910) | 3.6 |
1 The codes within brackets correspond to the International Classification of Diseases codes [46]
2 Scenario A: Sodium intake reduction by 10% (3.0 ± 1.2 g/day) for a 2171 kcal/day intake
3 Scenario B: Sodium intake reduction by 30% (2.4 ± 1.0 g/day) for a 2171 kcal/day intake- WHO goal for 2025 [39]
DPP, deaths prevented or postponed
* Others: Heart failure, aortic aneurysm, pulmonary embolism, and rheumatic heart disease